SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-04-007049
Filing Date
2004-12-17
Accepted
2004-12-17 15:29:27
Documents
1
Period of Report
2004-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2934
  Complete submission text file 0001140361-04-007049.txt   4902
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3385 WEST 1820 SOUTH SALT LAKE CITY UT 84104
Business Address 8019751191
SEMBER MICHAEL T (Reporting) CIK: 0001107486 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-16929 | Film No.: 041211298